Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLOS Global Public Health

Topics

Physics

Immunology

Medicine

Internal Medicine

Infectious Diseases

Show all topics

DOI

10.1371/journal.pgph.0003260

License

CC-BY

Other Formats

PDF